Test Strategy Review for FDA 510(k) — Bench & Performance Testing

The three types of 510(k) submissions are Traditional, Special, and Abbreviated 510(k). A Traditional 510(k) is the standard pathway for most devices. A Special 510(k) is typically used for certain modifications to a manufacturer's own legally marketed device. An Abbreviated 510(k) relies more heavily on recognized standards, guidance documents, and special controls to support substantial equivalence.

The 510(k) rule refers to the FDA requirement that many medical device manufacturers notify the agency before marketing a device in the United States. The submission must demonstrate substantial equivalence to a legally marketed predicate device. In practice, this means providing device descriptions, comparison logic, labeling, risk information, and appropriate performance evidence such as bench, software, biocompatibility, or other testing.

Bench and performance testing often provide the core objective evidence that a device performs as intended and is substantially equivalent to a predicate. These studies can address mechanical performance, electrical safety, software behavior, EMC, usability, sterility, or other device-specific characteristics. Weak or incomplete testing is a common reason for FDA questions, so the strategy behind the testing matters as much as the final reports.

A test strategy review typically evaluates which performance characteristics need to be tested, whether the selected standards and methods are appropriate, how acceptance criteria are justified, and whether the testing sequence supports the submission timeline. It also checks alignment with predicate comparisons, risk management outputs, labeling claims, and any FDA guidance relevant to the device type.

Yes. Early review is often the most valuable stage because it helps identify missing endpoints, unsuitable standards, weak protocol logic, or documentation gaps before studies begin. Elexes can review the proposed testing matrix, protocol rationale, and regulatory strategy in advance so manufacturers avoid spending time and budget on studies that may not fully support the 510(k).

Applicable standards are selected based on the device's intended use, technological characteristics, risk profile, and relevant FDA-recognized consensus standards or guidance documents. This may include ASTM, IEC, ISO, or AAMI standards depending on the product. The goal is not simply to cite standards, but to choose those that meaningfully support safety, performance, and substantial equivalence in the submission.

No. Many 510(k) submissions can be supported with bench, analytical, software, biocompatibility, electrical safety, EMC, sterilization, or other non-clinical evidence. However, some devices may still require clinical data if bench testing alone cannot adequately address performance questions or technological differences. A sound regulatory and testing strategy helps determine whether clinical evidence is necessary before the submission is assembled.

Yes. Elexes supports manufacturers in analyzing FDA deficiency questions, identifying the underlying testing or documentation issue, and preparing structured responses. This can include clarifying protocol rationale, strengthening performance summaries, addressing acceptance criteria, or coordinating additional evidence where needed. Well-organized responses reduce the chance of repeated questions and help keep the review process moving.